Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Venous thromboembolism. Introduction].

O de Divitiis1

  • 1Medicina d'Urgenza e di Pronto Soccorso Divisione di Cardioangiologia con UTIC, Università degli Studi Federico II, Napoli.

Minerva Cardioangiologica
|March 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classical pterional compared to the extended skull base approach for the removal of clinoidal meningiomas.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2012
Same author

Spinal meningiomas: age-related features.

Clinical neurology and neurosurgery·2010
Same author

Coronary vasoreactivity is not altered in young people with type 1 diabetes.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2010
Same author

Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery.

Advances and technical standards in neurosurgery·2008
Same author

Anterior thoracic intradural arachnoid cysts. Case report and review of the literature.

Neurosurgical focus·2006
Same author

Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure.

European journal of heart failure·2004
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Effective deep venous thrombosis (DVT) treatment prevents embolism and post-phlebothrombotic syndrome (PPS). Low molecular weight heparins (LMWH) offer advantages over traditional heparin for DVT management.

Area of Science:

  • Vascular Medicine
  • Hematology
  • Thrombosis Research

Background:

  • Deep venous thrombosis (DVT) poses significant risks, including acute embolism (potentially fatal) and chronic post-phlebothrombotic syndrome (PPS).
  • Untreated DVT can lead to extension or embolism in 60% of cases, with PPS affecting up to 70% of patients.
  • Current DVT treatment paradigms have evolved over decades, incorporating anticoagulants, thrombolytics, and low molecular weight heparins (LMWH).

Purpose of the Study:

  • To analyze current deep venous thrombosis (DVT) treatment strategies.
  • To review diagnostic, clinical, laboratory, and instrumental procedures for DVT.
  • To outline updated indications for DVT diagnosis and management.

Main Methods:

  • Review of established and emerging treatments for deep venous thrombosis (DVT).

Related Experiment Videos

  • Analysis of diagnostic modalities including clinical, laboratory, and instrumental assessments.
  • Evaluation of current therapeutic guidelines and indications for intervention.

    • Main Results:

    • Low molecular weight heparins (LMWH) demonstrate superior efficacy and ease of use compared to unfractionated heparin.
    • Combination therapy with thrombolytics and heparin shows no added benefit over heparin alone for standard DVT cases.
    • Surgical or catheter-based interventions are reserved for refractory cases or contraindications to anticoagulation.

    Conclusions:

    • Optimal deep venous thrombosis (DVT) management focuses on preventing acute embolism and late-stage post-phlebothrombotic syndrome (PPS).
    • LMWH represents a preferred anticoagulant option for DVT treatment due to improved outcomes and handling.
    • A comprehensive approach integrating diagnostics and evidence-based treatment is crucial for managing DVT effectively.